Phasic modulation of Wnt signaling enhances cardiac differentiation in human pluripotent stem cells by recapitulating developmental ontogeny

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1843, Issue 11, 2014, Pages 2394-2402

  Mehta, Ashish ^a   Ramachandra, Chrishan J A ^a   Sequiera, Glen L ^a   Sudibyo, Yuliansa ^a   Nandihalli, Manasi ^a   Yong, Pearly J A ^a   Koh, Cai Hong ^a   Shim, Winston ^a,b  

^a DEPARTMENT OF CARDIOLOGY   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Bone morphogenetic protein; Cardiomyocyte; Differentiation; Pluripotent stem cells; Wnt signaling

Indexed keywords

ACTIVIN A; BETA CATENIN; BONE MORPHOGENETIC PROTEIN 4; MYOSIN LIGHT CHAIN 2; NOGGIN; STEM CELL FACTOR RECEPTOR; TRANSCRIPTION FACTOR GATA 4; TRANSCRIPTION FACTOR NKX2.5; TROPONIN T; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2; WNT11 PROTEIN; WNT2 PROTEIN; WNT3 PROTEIN; WNT3A PROTEIN; WNT5A PROTEIN; WNT5B PROTEIN;

ARTICLE; CANONICAL WNT SIGNALING PATHWAY; CELL DIFFERENTIATION; CONTROLLED STUDY; EMBRYONIC STEM CELL; GENE EXPRESSION; HEART DEVELOPMENT; HEART MUSCLE CELL; HUMAN; HUMAN CELL; MODULATION; NON CANONICAL WNT SIGNALING PATHWAY; ONTOGENY; PHASIC MODULATION; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; UPREGULATION; WNT SIGNALING PATHWAY;

EID: 84904900511     PISSN: 01674889     EISSN: 18792596     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2014.06.011     Document Type: Article

References (45)

1. Mehta A., Chung Y.Y., Ng A., Iskandar F., Atan S., Wei H., Dusting G., Sun W., Wong P., Shim W. Pharmacological response of human cardiomyocytes derived from virus-free induced pluripotent stem cells. Cardiovasc. Res. 2011, 91:577-586.
2. Osafune K., Caron L., Borowiak M., Martinez R.J., Fitz-Gerald C.S., Sato Y., Cowan C.A., Chien K.R., Melton D.A. Marked differences in differentiation propensity among human embryonic stem cell lines. Nat. Biotechnol. 2008, 26:313-315.
3. Mehta A., Mathew S., Viswanathan C., Sen Majumdar A. Intrinsic properties and external factors determine the differentiation bias of human embryonic stem cell lines. Cell Biol. Int. 2010, 34:1021-1031.
4. Moretti A., Bellin M., Welling A., Jung C.B., Lam J.T., Bott-Flugel L., Dorn T., Goedel A., Hohnke C., Hofmann F., Seyfarth M., Sinnecker D., Schomig A., Laugwitz K.L. Patient-specific induced pluripotent stem-cell models for long-QT syndrome. N. Engl. J. Med. 2010, 363:1397-1409.
5. Yazawa M., Hsueh B., Jia X., Pasca A.M., Bernstein J.A., Hallmayer J., Dolmetsch R.E. Using induced pluripotent stem cells to investigate cardiac phenotypes in Timothy syndrome. Nature 2011, 471:230-234.
6. Mehta A., Shim W. Cardiac stem cell therapy: stemness or commitment?. Cell Transplant. 2013, 22:1-14.
7. Mehta A., Chung Y., Sequiera G.L., Wong P., Liew R., Shim W. Pharmacoelectrophysiology of viral-free induced pluripotent stem cell-derived human cardiomyocytes. Toxicol. Sci. 2013, 131:458-469.
8. Davis R.P., van den Berg C.W., Casini S., Braam S.R., Mummery C.L. Pluripotent stem cell models of cardiac disease and their implication for drug discovery and development. Trends Mol. Med. 2011, 17:475-484.
9. Braam S.R., Tertoolen L., van de Stolpe A., Meyer T., Passier R., Mummery C.L. Prediction of drug-induced cardiotoxicity using human embryonic stem cell-derived cardiomyocytes. Stem Cell Res. 2010, 4:107-116.
10. Braam S.R., Passier R., Mummery C.L. Cardiomyocytes from human pluripotent stem cells in regenerative medicine and drug discovery. Trends Pharmacol. Sci. 2009, 30:536-545.
11. Noseda M., Peterkin T., Simoes F.C., Patient R., Schneider M.D. Cardiopoietic factors: extracellular signals for cardiac lineage commitment. Circ. Res. 2011, 108:129-152.
12. Gessert S., Kuhl M. The multiple phases and faces of wnt signaling during cardiac differentiation and development. Circ. Res. 2010, 107:186-199.
13. van Wijk B., Moorman A.F., van den Hoff M.J. Role of bone morphogenetic proteins in cardiac differentiation. Cardiovasc. Res. 2007, 74:244-255.
14. Lindsley R.C., Gill J.G., Kyba M., Murphy T.L., Murphy K.M. Canonical Wnt signaling is required for development of embryonic stem cell-derived mesoderm. Development 2006, 133:3787-3796.
15. Bondue A., Blanpain C. Mesp1: a key regulator of cardiovascular lineage commitment. Circ. Res. 2010, 107:1414-1427.
16. Bondue A., Lapouge G., Paulissen C., Semeraro C., Iacovino M., Kyba M., Blanpain C. Mesp1 acts as a master regulator of multipotent cardiovascular progenitor specification. Cell Stem Cell 2008, 3:69-84.
17. Mummery C., Ward-van Oostwaard D., Doevendans P., Spijker R., van den Brink S., Hassink R., van der Heyden M., Opthof T., Pera M., de la Riviere A.B., Passier R., Tertoolen L. Differentiation of human embryonic stem cells to cardiomyocytes: role of coculture with visceral endoderm-like cells. Circulation 2003, 107:2733-2740.
18. Laflamme M.A., Chen K.Y., Naumova A.V., Muskheli V., Fugate J.A., Dupras S.K., Reinecke H., Xu C., Hassanipour M., Police S., O'Sullivan C., Collins L., Chen Y., Minami E., Gill E.A., Ueno S., Yuan C., Gold J., Murry C.E. Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nat. Biotechnol. 2007, 25:1015-1024.
19. Yang L., Soonpaa M.H., Adler E.D., Roepke T.K., Kattman S.J., Kennedy M., Henckaerts E., Bonham K., Abbott G.W., Linden R.M., Field L.J., Keller G.M. Human cardiovascular progenitor cells develop from a KDR+embryonic-stem-cell-derived population. Nature 2008, 453:524-528.
20. Kattman S.J., Witty A.D., Gagliardi M., Dubois N.C., Niapour M., Hotta A., Ellis J., Keller G. Stage-specific optimization of activin/nodal and BMP signaling promotes cardiac differentiation of mouse and human pluripotent stem cell lines. Cell Stem Cell 2011, 8:228-240.
21. Xu X.Q., Graichen R., Soo S.Y., Balakrishnan T., Rahmat S.N., Sieh S., Tham S.C., Freund C., Moore J., Mummery C., Colman A., Zweigerdt R., Davidson B.P. Chemically defined medium supporting cardiomyocyte differentiation of human embryonic stem cells. Differentiation 2008, 76:958-970.
22. Sequiera G.L., Mehta A., Ooi T.H., Shim W. Ontogenic development of cardiomyocytes derived from transgene-free human induced pluripotent stem cells and its homology with human heart. Life Sci. 2013, 92:63-71.
23. Graichen R., Xu X., Braam S.R., Balakrishnan T., Norfiza S., Sieh S., Soo S.Y., Tham S.C., Mummery C., Colman A., Zweigerdt R., Davidson B.P. Enhanced cardiomyogenesis of human embryonic stem cells by a small molecular inhibitor of p38 MAPK. Differentiation 2008, 76:357-370.
24. Rajala K., Pekkanen-Mattila M., Aalto-Setala K. Cardiac differentiation of pluripotent stem cells. Stem Cells Int. 2011, 2011:383709.
25. Elliott D.A., Braam S.R., Koutsis K., Ng E.S., Jenny R., Lagerqvist E.L., Biben C., Hatzistavrou T., Hirst C.E., Yu Q.C., Skelton R.J., Ward-van Oostwaard D., Lim S.M., Khammy O., Li X., Hawes S.M., Davis R.P., Goulburn A.L., Passier R., Prall O.W., Haynes J.M., Pouton C.W., Kaye D.M., Mummery C.L., Elefanty A.G., Stanley E.G. NKX2-5(eGFP/w) hESCs for isolation of human cardiac progenitors and cardiomyocytes. Nat. Methods 2011, 8:1037-1040.
26. Mehta A., Sequiera G.L., Ramachandra C.J., Sudibyo Y., Chung Y., Sheng J., Wong K.Y., Tan T.H., Wong P., Liew R., Shim W. Re-trafficking of hERG reverses long QT syndrome 2 phenotype in human iPS-derived cardiomyocytes. Cardiovasc. Res. 2014, 102:497-506.
27. Chen Y., Amende I., Hampton T.G., Yang Y., Ke Q., Min J.Y., Xiao Y.F., Morgan J.P. Vascular endothelial growth factor promotes cardiomyocyte differentiation of embryonic stem cells. Am. J. Physiol. Heart Circ. Physiol. 2006, 291:H1653-H1658.
28. Vidarsson H., Hyllner J., Sartipy P. Differentiation of human embryonic stem cells to cardiomyocytes for in vitro and in vivo applications. Stem Cell Rev. 2010, 6:108-120.
29. Cao N., Liu Z., Chen Z., Wang J., Chen T., Zhao X., Ma Y., Qin L., Kang J., Wei B., Wang L., Jin Y., Yang H.T. Ascorbic acid enhances the cardiac differentiation of induced pluripotent stem cells through promoting the proliferation of cardiac progenitor cells. Cell Res. 2012, 22:219-236.
30. Bowers S.L., Banerjee I., Baudino T.A. The extracellular matrix: at the center of it all. J. Mol. Cell. Cardiol. 2010, 48:474-482.
31. Niwa H., Miyazaki J., Smith A.G. Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells. Nat. Genet. 2000, 24:372-376.
32. Zeineddine D., Papadimou E., Chebli K., Gineste M., Liu J., Grey C., Thurig S., Behfar A., Wallace V.A., Skerjanc I.S., Puceat M. Oct-3/4 dose dependently regulates specification of embryonic stem cells toward a cardiac lineage and early heart development. Dev. Cell 2006, 11:535-546.
33. Li Y., Yu W., Cooney A.J., Schwartz R.J., Liu Y. Brief report: Oct4 and canonical Wnt signaling regulate the cardiac lineage factor Mesp1 through a Tcf/Lef-Oct4 composite element. Stem Cells 2013, 31:1213-1217.
34. Lian X., Hsiao C., Wilson G., Zhu K., Hazeltine L.B., Azarin S.M., Raval K.K., Zhang J., Kamp T.J., Palecek S.P. Robust cardiomyocyte differentiation from human pluripotent stem cells via temporal modulation of canonical Wnt signaling. Proc. Natl. Acad. Sci. U. S. A. 2012, 109:E1848-E1857.
35. Filipczyk A.A., Passier R., Rochat A., Mummery C.L. Regulation of cardiomyocyte differentiation of embryonic stem cells by extracellular signalling. Cell. Mol. Life Sci. 2007, 64:704-718.
36. Ueno S., Weidinger G., Osugi T., Kohn A.D., Golob J.L., Pabon L., Reinecke H., Moon R.T., Murry C.E. Biphasic role for Wnt/beta-catenin signaling in cardiac specification in zebrafish and embryonic stem cells. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:9685-9690.
37. Afouda B.A., Martin J., Liu F., Ciau-Uitz A., Patient R., Hoppler S. GATA transcription factors integrate Wnt signalling during heart development. Development 2008, 135:3185-3190.
38. Pandur P., Lasche M., Eisenberg L.M., Kuhl M. Wnt-11 activation of a non-canonical Wnt signalling pathway is required for cardiogenesis. Nature 2002, 418:636-641.
39. Eisenberg C.A., Gourdie R.G., Eisenberg L.M. Wnt-11 is expressed in early avian mesoderm and required for the differentiation of the quail mesoderm cell line QCE-6. Development 1997, 124:525-536.
40. Yan D., Wallingford J.B., Sun T.-Q., Nelson A.M., Sakanaka C., Reinhard C., Harland R.M., Fantl W.J., Williams L.T. Cell autonomous regulation of multiple dishevelled-dependent pathways by mammalian Nkd. Proc. Natl. Acad. Sci. 2001, 98:3802-3807.
41. Wharton K.A., Zimmermann G., Rousset R., Scott M.P. Vertebrate proteins related to drosophila naked cuticle bind dishevelled and antagonize Wnt signaling. Dev. Biol. 2001, 234:93-106.
42. Cha S.-W., Tadjuidje E., Tao Q., Wylie C., Heasman J. Wnt5a and Wnt11 interact in a maternal Dkk1-regulated fashion to activate both canonical and non-canonical signaling in Xenopus axis formation. Development 2008, 135:3719-3729.
43. Cha S.-W., Tadjuidje E., White J., Wells J., Mayhew C., Wylie C., Heasman J. Wnt11/5a complex formation caused by tyrosine sulfation increases canonical signaling activity. Curr. Biol. 2009, 19:1573-1580.
44. Tseng A.S., Engel F.B., Keating M.T. The GSK-3 inhibitor BIO promotes proliferation in mammalian cardiomyocytes. Chem. Biol. 2006, 13:957-963.
45. Mehta A., Verma V., Nandihalli M., Ramachandra C.J.A., Sequiera G.L., Sudibyo Y., Chung Y.Y., Sun W., Shim W. A systemic evaluation of cardiac differentiation from mRNA reprogrammed human induced pluripotent stem cells. PloS One 2014, 2014.